Silibinin: an inhibitor for a high-expressed BCL-2A1/BFL1 protein, linked with poor prognosis in breast cancer.

MLA

Gupta, Shradheya R. R., et al. “Silibinin: An Inhibitor for a High-Expressed BCL-2A1/BFL1 Protein, Linked with Poor Prognosis in Breast Cancer.” Journal of Biomolecular Structure & Dynamics, vol. 42, no. 22, Dec. 2024, pp. 12122–32. EBSCOhost, https://doi.org/10.1080/07391102.2023.2268176.

APA

Gupta, S. R. R., Mittal, P., Kundu, B., Singh, A., & Singh, I. K. (2024). Silibinin: an inhibitor for a high-expressed BCL-2A1/BFL1 protein, linked with poor prognosis in breast cancer. Journal of Biomolecular Structure & Dynamics, 42(22), 12122–12132. https://doi.org/10.1080/07391102.2023.2268176

Chicago

Gupta, Shradheya R. R., Pooja Mittal, Bishwajit Kundu, Archana Singh, and Indrakant K. Singh. 2024. “Silibinin: An Inhibitor for a High-Expressed BCL-2A1/BFL1 Protein, Linked with Poor Prognosis in Breast Cancer.” Journal of Biomolecular Structure & Dynamics 42 (22): 12122–32. doi:10.1080/07391102.2023.2268176.